PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Hearing Loss 30,622 Disease Target AKT2 873 1 0.00 -1.00 0.00 0.53
3-Phosphoinositide-Dependent Protein Kinase 1 230 Target Target AKT2 873 1 0.00 -1.00 0.00 0.66
Phosphodiesterase 4b 54 Target Target AKT2 873 1 0.00 -0.99 0.02 0.68
Non Small Cell Lung Cancer 28,563 Disease Target AKT2 873 14 0.00 -0.99 0.02 0.60
Endometriosis 16,342 Disease Target AKT2 873 2 0.00 -1.00 0.00 0.56
Obesity 138,233 Disease Target AKT2 873 33 0.00 -0.98 0.04 0.58
CCNB1 160 Target Target AKT2 873 1 0.00 -1.00 0.01 0.66
Epidermal Growth Factor Receptor 24,772 Target Target AKT2 873 16 0.00 -0.99 0.02 0.61
CXCL16 341 Target Target AKT2 873 1 0.00 -1.00 0.00 0.65
Osteoarthritis 36,287 Disease Target AKT2 873 1 0.00 -1.00 0.00 0.53
CD68 6,424 Target Target AKT2 873 1 0.00 -1.00 0.00 0.57
Depression 220,092 Disease Target AKT2 873 2 0.00 -1.00 0.00 0.50
Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 Target Target AKT2 873 1 0.00 -1.00 0.00 0.57
Hepatitis 163,842 Disease Target AHSG 176 3 0.00 -0.99 0.02 0.55
AFP 9,751 Target Target AHSG 176 1 0.00 -1.00 0.01 0.59
Osteoarthritis 36,287 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.56
Ovarian Cancer 33,996 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.56
Shock 134,031 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.53
Collagen 138,882 Target Target AHSG 176 4 0.00 -0.99 0.02 0.56
Osteoporosis 46,215 Disease Target AHSG 176 7 0.00 -0.98 0.04 0.60
Arrhythmia 29,330 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.56
Hyperglycemia 28,168 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.56
Multiple Myeloma 24,594 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.57
AMBP 160 Target Target AHSG 176 1 0.01 -0.99 0.01 0.72
Menopause 19,680 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.57
Diabetes 332,602 Disease Target AHSG 176 21 0.00 -0.94 0.12 0.58
Renal Failure 73,993 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.54
Myeloperoxidase 16,181 Target Target AHSG 176 1 0.00 -1.00 0.01 0.58
ACTG1 41 Target Target AHSG 176 1 0.01 -0.98 0.02 0.74
Carcinoma 433,099 Disease Target AHSG 176 7 0.00 -0.98 0.04 0.55
Epidermal Growth Factor Receptor 24,772 Target Target AHSG 176 1 0.00 -1.00 0.01 0.57
Sedimentation Rate 11,455 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.59
Fracture 111,575 Disease Target AHSG 176 4 0.00 -0.99 0.02 0.56
BMP-7 1,112 Target Target AHSG 176 2 0.00 -0.99 0.01 0.68
Pneumonia 81,521 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.54
ERK1 18,374 Target Target AHSG 176 2 0.00 -0.99 0.01 0.59
Stroke 146,992 Disease Target AHSG 176 5 0.00 -0.99 0.03 0.56
Endometriosis 16,342 Disease Target AHSG 176 2 0.00 -0.99 0.01 0.60
Arthritis 128,324 Disease Target AHSG 176 2 0.00 -0.99 0.01 0.54
APOA2 118 Target Target AHSG 176 1 0.01 -0.99 0.01 0.73
APOE 12,771 Target Target AHSG 176 2 0.00 -0.99 0.01 0.60
Adiponectin 11,994 Target Target AHSG 176 3 0.00 -0.99 0.02 0.62
Infection 766,637 Disease Target AHSG 176 3 0.00 -0.99 0.02 0.52
Lung Carcinoma 13,423 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.58
APOH 110 Target Target AHSG 176 1 0.01 -0.99 0.01 0.73
Diabetic Nephropathy 12,496 Disease Target AHSG 176 1 0.00 -1.00 0.01 0.58
C4A 1,177 Target Target AHSG 176 1 0.00 -1.00 0.01 0.65
Endostatin 1,599 Target Target AHSG 176 1 0.00 -1.00 0.01 0.64
Obesity 138,233 Disease Target AHSG 176 13 0.00 -0.96 0.07 0.59
Rheumatoid Arthritis 78,952 Disease Target AHSG 176 2 0.00 -0.99 0.01 0.56